chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had vaccination on 09/30/2022. On 11/29/2022 I had a cough that gradually got worse over 4 days. It entered the lungs with congestion and lasted about 10 days. I tested COVID-19 negative on 11/29/2022 and 11/30/2022.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 25-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), on 30Nov2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 24 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 02Jan2022 as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "spinal cord injury" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300237641 Same patient, different drug/AE.;
Fever; Chills; Aches; Headache; This is a spontaneous report from a contactable HCP (Pharmacist) reported for a female patient. A 45-year-old adult female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: Unknown), dose 2 via an intramuscular route of administration on 27Feb2021 (at the age of 45-year-old), as DOSE 2, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient medical history and concomitant medications were not reported. The patient had no covid prior vaccination. The patient previously received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: Unknown), via an intramuscular route of administration on 06Feb2021, as single for covid-19 immunisation. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown since the vaccination the patient had been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. On 01Mar2021 at 04:00 AM, the patient experienced fever, chills, aches and headache. Patient received treatment with Tylenol to treat the events. The patient outcome of the events was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
I had a swollen lymph node underneath my left arm. My gynecologists noticed it was swollen and I could not get my mammogram. A few weeks later I develop shingles, I did not go to the doctors for it. It took four to six months before the swelling went away. I didn't have any treatment for the lymph node. The doctor stated it would go away on its own.
Information has been received from a physician concerning a 19 month old patient who on 03/06/2001 was vaccinated with a dose of varicella virus vaccine live.  On 03/16/2001 the patient experienced a case of breakthrough varicella.  It was noted that it was from the vaccine.  There were less than 50 lesions.  Unspecified medical attention was sought, but there was no treatment and no hospitalization.  The patient recovered.  No product quality complaint was involved.  This is one patient out of 40 reported.  Thirty nine other cases experienced breakthrough varicella after vaccination with varicella virus vaccine live.  Additional information is not expected.
Patient had vaccines on 7/15/20. Around 7/17/20 to 7/18/20, mother noted patient not making as much typical vocalizations. Saw in clinic myself on 7/27/20, by then, mother said almost back to baseline.
Possible allergic reaction; had shot #2 of the shingrix vaccine and am experiencing fever like / Fever is only 100.1; This case was reported by a consumer via call center representative and described the occurrence of allergic reaction in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pyrexia (1st dose received few months before 2nd dose, refer linked case US2020AMR044130).   On 9th March 2020, the patient received the 2nd dose of Shingrix. In March 2020, less than a week after receiving Shingrix, the patient experienced fever. On an unknown date, the patient experienced allergic reaction. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the allergic reaction and fever were unknown.   It was unknown if the reporter considered the allergic reaction and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group of patient was not reported but was captured as an adult as per vaccine indication. A day before reporting, the patient received 2nd dose of Shingrix, and experienced fever. The fever was 100.1 Degree F. The patient asked that he/she should considered it as an allergic reaction or not. The patient did not had any other issue just had fever.
My doctor encouraged me to report this but I don't know if it meets your criteria.  I had for all practical purposes reached menopause.  About a week and a half I had my period for the first time in over a year.  I then, more recently had an even stronger cycle, a little over 3 weeks after my 2nd vaccine.   This second cycle, while quite heavy, lasted a typical period of time for me.  Approx. two days of heavy flow and then quickly tapering off.
Initial information received on 10-Sep-2018 regarding an unsolicited valid non-serious case received from a Pharmacist. This case is linked to case 2018SA256369 (same reporter). This case involves a five years old male patient who was vaccinated with FLUBLOK QIV (lot number QFAA1814, expiry date: 30-Jun-2019) via unknown route in the left thigh on 10-Sep-2018. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included QUADRACEL; and MMRVAXPRO. It was an actual medication error due to inappropriate age at vaccine administration. No Reported symptoms. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
12/17 at 2?3 pm- Had a mild headache that progressed to severe within an hour. Became diaphoretic, felt dizzy, nauseated. Had GI distress and vomiting episode.  Medicated with Tylenol and slept for 8 hours. 12/18  feel back to normal. No fevers
Fever, ache, headache, fatigue, vomiting, chill, back pain.
Right shoulder sharp, severe pain 2 days post injection. Loss of ROM, increasing pain and atrophy of deltoid and shoulder muscles over the course of 11 months.
12 hrs. after I got the vaccine, I was sleeping, woke up and saw in the mirror I had a spam and it lasted for three weeks, sometimes I saw it and feel it, a week later my right eye, started on the left and then the right eye. A month after the vaccine, I notice itching on my eyebrow and had pain it happens for a few weeks, after a few weeks, two months after, I still had eye pain, On December I saw a Neurologist, gave me an exam, she thought it was not the vaccine, but it was 12 hrs. after the vaccine, and it didn't have the before.
After about 10 minutes after receiving shot I got a tingling sensation in the left side of my face and a stiffness and tightness with some swelling.  The stiffness continued to get worse over time and moved across my face, my jawline, chine, above my lip, under my right eye, and my forehead.  The stiffness has persisted for 3 weeks at which time I went to my doctor.
Pain in arm; Fatigue; Sleep excessive; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), HYPERSOMNIA (Sleep excessive) and FATIGUE (Fatigue) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 025120-2A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SALBUTAMOL (VENTOLIN [SALBUTAMOL]) for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HYPERSOMNIA (Sleep excessive). On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arm) and FATIGUE (Fatigue). At the time of the report, PAIN IN EXTREMITY (Pain in arm), HYPERSOMNIA (Sleep excessive) and FATIGUE (Fatigue) had resolved.            Consumer reported the events resolved within a few days. Treatment information not provided. Action taken for Moderna COVID-19 Vaccine was not applicable.   This case was linked to MOD-2021-025819 (Patient Link).
Pt has a red rash around injection site, R arm. Instructed mom to put cool compress on the rash.
This case was reported by an other health professional via sales rep and described the occurrence of pain in arm in an adolescent female patient who received BEXSERO for prophylaxis. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, unknown after receiving BEXSERO, the patient experienced pain in arm and adverse event. On an unknown date, the outcome of the pain in arm was recovered/resolved and the outcome of the adverse event was unknown. It was unknown if the reporter considered the pain in arm and adverse event to be related to BEXSERO. Additional details were provided as follows: This case was reported by Certified Medical Assistant (CMA). The age at vaccination was not reported. The patient experienced arm soreness 5 days out and other reactions. The reporter agreed for follow up contact.
He passed in his sleep that night.; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (He passed in his sleep that night.) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Death occurred on 22-Jul-2021 The patient died on 22-Jul-2021. The cause of death was not reported. It is unknown if an autopsy was performed.            No concomitant medication was given. No treatment information was given. Patient received the 1st dose of the Moderna Covid-19 vaccine. He died in his sleep that night.  This a report of dead one day after the first dose of the product in an 52-year-old patient with no comorbidities. Very limited information regarding the event has been provided for inferring causality. Further information is not expected.; Sender's Comments: This a report of dead one day after the first dose of the product in an 52-year-old patient with no comorbidities. Very limited information regarding the event has been provided for inferring causality. Further information is not expected.; Reported Cause(s) of Death: unknown
Hives started forming all over body on 9/17/2022 and lasted until 9/20/2022. This was my 4th Covid vaccine - I received 3 Moderna vaccines previously (1/22/2021; 2/19/2021; 11/18/2021)
On 04-16-2021 I experienced I could feel tingling sensation on my let arm and face, lasting couple of hours. Earlier that night, I woke up I was cold, my temperature was 99.F.  For the rest of the week of Friday morning wok up with headaches, focused at temple, left side of my head. I still had some tingling to my left arm radiating to my left pinky finger. My tingling sensation and headaches come and go and come back again on and off.  I went to see a physician 04-23-2021 and did blood work which was negative. On 04-28-2021 I saw a neurologist on 04-28-2021. I have had this tingling sensation to my body before due to a parasite, previous history. She states that it sounded that the vaccine caused a flare up t my body and recommend treatment steroid injections to my temples and neck. She states this injections work about 70% of the time. She also prescribed muscle relaxer and take Vitamin D complex. Herdiagnosis was related to nerve damage due to the flare up.
Bedridden due to flu like symptoms, fever, aches, headache, congestion in head.
Post menopausal Vaginal bleeding x1 day beginning night of vaccination; This is a spontaneous report from a contactable consumer (patient). A 65-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and expiration dates were not reported), dose 1 via unknown route administration at left arm on 01Sep2021 at 11:00 am (age at vaccination 65-year-old) as single dose for COVID-19 immunisation. The patient had allergy to sulfa from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient medical history included endometrial cancer with hysterectomy, asthma, hypothyroid, arthritis, retinal detachment and choledocholithiasis from an unknown date and unknown if ongoing. The patient took other medications in two weeks included amlodipine, levothyroxine, ursodiol, tramadol and vitamin B1 from an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient had post-menopausal vaginal bleeding in 1 day beginning night of vaccination on 02Sep2021 at 12:00 am. The patient had not received any treatment for the event. The patient underwent lab tests and procedures which included Sars-cov-2 test (Nasal swab): Negative on 01Sep2021. The Facility where the most recent COVID-19 vaccine administered was Doctor's office/urgent care. The patient did not receive any treatment for the adverse event. The outcome of the event was recovered on an unknown date in 2021.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow-up.
Swelling and large welt like lump in area of injection site. Appeared about 12 hours after injection and has been getting larger since.
Patient developed rhabdomyolysis in his left arm within 8 days of having meningitis B vaccine.
This spontaneous report as received from a Nurse refers to multiple unspecified patients. On unknown dates the patients were vaccinated with improperly stored GARDASIL 9 (lot number, expiration date, dose and route unknown) for prophylaxis. No adverse effects reported. The vaccine was exposed to 47 Fahrenheit (F) to 77 F (47.5F) for 888 hours. This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-1708USA010403: US-009507513-1708USA010402: US-009507513-1708USA010400: US-009507513-1708USA010320:
Systemic: Chest Tightness / Heaviness / Pain-Severe, Systemic: Shakiness-Mild, Additional Details: Pt came into pharamcy and told me a few weeks later about how his second vaccaine was due and reported AE to me. Pt expereinced chest tightness and pain. he went to ER and they told him he had been diagnosted with "mini heart attack". Pt was told to F/U with PCP. I talked to pateint and told him not to get naother dose until PCP or caridologist appoitnment is made. Shared a few providers in the area and recomended going closer to get the best care. Pt seems to have recoved event
Case number PHEH2043US025228, is an initial spontaneous report received from a nurse on 03 DEC 2013. This report refers to a 15-year-old male patient. Past medical history and concomitant medication were not reported. He was vaccinated with FLUCELVAX (batch number: 009031A and expiry date: JUN 2014) at a dose of 0.5 ml intramuscularly on 20 NOV 2013. No adverse event was reported following this administration error.  Following an internal review on 18 AUG 2014, a significant correction was done for the information received on 03 DEC 2013. The BPI labeling of the event "inappropriate age at vaccine administration " changed from listed to unlisted and added second indication as "drug used in unapproved population".
Pt stated the night after receiving Gardasil she started itching all over body. Went to ER 11/18/2012. Was given Zyrtec, Hydrozine, Benadryl but continues itching.
I experienced a constant high-pitched ringing in my ears after the first dose that lasted a couple days. After the second dose, it came back and subsided in my left ear after 4 days or so, but has remained in my right ear.
A report has been received from a Health Professional concerning multiple patients of unknown age and gender, who had been receiving Nasal FLUMIST (INTRANASAL) started on an unknown date. It was reported that SIBLINGS RECEIVED FLUMIST QUAD AND LATER TESTED POSITIVE FOR INFLUENZA THIS SEASON. The outcome of the event of SIBLINGS RECEIVED FLUMIST QUAD AND LATER TESTED POSITIVE FOR INFLUENZA THIS SEASON is unknown. The report was considered to be non-serious by the reporter.
Headache; Chills; Joint pain; Muscle pain; she get the second vaccine three months later; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (Chills), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (she get the second vaccine three months later) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), CHILLS (Chills), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (she get the second vaccine three months later). At the time of the report, HEADACHE (Headache), CHILLS (Chills) and ARTHRALGIA (Joint pain) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment information was given.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Significant follow up appended. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (Chills), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (she get the second vaccine three months later) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), CHILLS (Chills), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (she get the second vaccine three months later). At the time of the report, HEADACHE (Headache), CHILLS (Chills) and ARTHRALGIA (Joint pain) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment information was given.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Significant follow up appended.
pt states she has chills that goes from her her arms to her legs.   She says the chills will start in her upper body and then will move down into the lower body.  She does not have any fever.  She says it feels very weird.  she has had these symptoms since taking the second dose.
Received Varivax immunization Oct and Nov 2006 based upon negative titer results. Patient developed visual disturbance,left eye droopiness and numbness to left face and arm in March 2007.  Patient was seen by her primary physician and diagnosed with Bell's Palsy. She received 12 session of physician therapy from 4-16 to 5-11 with some improvement. She has been referred to a neurologist in July 2007.
10 minutes after her first dose she had been sitting in a chair & developed diaphoresis, warm skin, loss of vision,& low blood pressure. Pt was initially not responsive, when transferred to a wheel chair to take her to a gurney, left arm & left leg jerk twice. Took her to lay down and check her blood pressure. En route, in the wheel chair within about 5 to 10 seconds, she became responsive and said she could not see. Her vision returned to normal within a minute. Her initial blood pressure was 97/64 with O2 Sat 100% on room air. Her skin temp was 95.5, and her HR was 95. She continued to be responsive with excellent oxygenation and When the EMTs arrived she had a blood sugar of 90 and improving blood pressure with a regular rate and rhythm. Her diaphoresis resolved, and she continued to improve, tolerating water. Had similar reaction last year to flu shot, no hx of seizures